Contact

Richard Paxman OBE, CEO of Paxman, will join Redeye Life Science Day 2023

Along with additional Nordic companies, at the forthcoming live-streamed Redeye Life Science Day 2023, Richard will deliver an insight into Paxman followed by an in-depth 20-minute interview.
One-to-one meetings can also be facilitated.
 
When: November 23
Time: 08.00-16.00
Where: Live broadcast and special invitees only
Event link:
https://www.redeye.se/events/915984/redeye-life-science-day-2023

Richard Paxman OBE, CEO of Paxman, will join Redeye Life Science Day 2023 Richard Paxman OBE, CEO of Paxman, will join Redeye Life Science Day 2023
What we do
Paxman are world leaders in chemotherapy side effect management on an ambitious journey to change the face of cancer through cryotherapy-based treatments. The Paxman mission is to democratise access to scalp cooling globally.
Learn more →
Financial Information
Read the latest Paxman financial reports. In these comprehensive documents, you will find a detailed overview of our financial performance, key milestones, and a strategic outlook for the future. Reports are published quarterly and annually.
Read reports  →
Investing in Paxman
Paxman has treated 100,000+ patients and installed 5,000+ systems in more than 65 countries worldwide. We are helping to manage the trauma of chemotherapy hair loss. By investing in Paxman, you're not just supporting a company; you're joining us in changing the face of cancer.
Visit the Investor Centre →
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram